Elevated Circulating Sclerostin Concentrations in Individuals With High Bone Mass, With and Without LRP5 Mutations (vol 99, pg 2897, 2014)

被引：1
|
作者：
Gregson, C. L.
Poole, K. E. S.
McCloskey, E., V
Duncan, E. L.
Rittweger, J.
Fraser, W. D.
Smith, G. D.
Tobias, J. H.
机构：
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2015年 / 100卷 / 08期
关键词：
D O I：
10.1210/jc.2015-2231
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3219 / 3219
页数：1
相关论文
共 21 条
  • [1] Elevated Circulating Sclerostin Concentrations in Individuals With High Bone Mass, With and Without LRP5 Mutations
    Gregson, Celia L.
    Poole, Kenneth E. S.
    McCloskey, Eugene V.
    Duncan, Emma L.
    Rittweger, Joern
    Fraser, William D.
    Smith, George Davey
    Tobias, Jonathan H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (08): : 2897 - 2907
  • [2] The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations
    Wendy Balemans
    Elke Piters
    Erna Cleiren
    Minrong Ai
    Liesbeth Van Wesenbeeck
    Matthew L. Warman
    Wim Van Hul
    Calcified Tissue International, 2008, 82 : 445 - 453
  • [3] The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations
    Balemans, Wendy
    Piters, Elke
    Cleiren, Erna
    Ai, Minrong
    Van Wesenbeeck, Liesbeth
    Warman, Matthew L.
    Van Hul, Wim
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (06) : 445 - 453
  • [4] Measurement of Plasma, Serum, and Platelet Serotonin in Individuals With High Bone Mass and Mutations in LRP5
    Lee, Grace S.
    Simpson, Christine
    Sun, Ben-Hua
    Yao, Chen
    Foer, Dinah
    Sullivan, Becky
    Matthes, Susann
    Alenina, Natalia
    Belsky, Joseph
    Bader, Michael
    Insogna, Karl L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (04) : 976 - 981
  • [5] The binding between sclerostin and LRP5 is drastically impaired bothan high-bone-mass LRP5 mutants and in the presence of DKKI
    Balemans, W.
    Cleiren, E.
    Ai, M.
    Van Wesenbeeck, L.
    Warman, M. L.
    Van Hul, W.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S27 - S27
  • [6] LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST
    Semenov, Mikhail V.
    He, Xi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (50) : 38276 - 38284
  • [7] High-bone-mass disease and LRP5 (vol 350, pg 2096, 2004)
    Whyte
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (10): : 1038 - 1038
  • [8] High bone mass due to novel LRP5 and AMER1 mutations
    Costantini, Alice
    Kekalainen, Paivi
    Makitie, Riikka E.
    Makitie, Outi
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2017, 60 (12) : 675 - 679
  • [9] Mutations in LRP5 and SOST are a rare cause of high bone mass in the general population
    Duncan, E. L.
    Gregson, C. L.
    Addison, K.
    Brugmans, M.
    Pointon, J. J.
    Appleton, L. H.
    Tobias, J. H.
    Brown, M. A.
    BONE, 2009, 44 (02) : S340 - S341
  • [10] The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5
    Yorgan, Timur A.
    Peters, Stephanie
    Jeschke, Anke
    Benisch, Peggy
    Jakob, Franz
    Amling, Michael
    Schinke, Thorsten
    JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (07) : 1175 - 1183
123